|
1
|
Yi JS, Cox MA and Zajac AJ: T-cell
exhaustion: Characteristics, causes and conversion. Immunology.
129:474–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wherry EJ: T cell exhaustion. Nat Immunol.
12:492–499. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crawford A and Wherry EJ: The diversity of
costimulatory and inhibitory receptor pathways and the regulation
of antiviral T cell responses. Curr Opin Immunol. 21:179–186. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen L and Flies DB: Molecular mechanisms
of T cell co-stimulation and co-inhibition. Nat Rev Immunol.
13:227–242. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carreno BM, Carter LL and Collins M:
Therapeutic opportunities in the B7/CD28 family of ligands and
receptors. Curr Opin Pharmacol. 5:424–430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anand S and Chen L: Control of autoimmune
diseases by the B7-CD28 family molecules. Curr Pharm Des.
10:121–128. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C,
Niu JQ and Jiang YF: Treatment with telbivudine positively
regulates antiviral immune profiles in Chinese patients with
chronic hepatitis B. Antimicrob Agents Chemother. 57:1304–1311.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zelinskyy G, Myers L, Dietze KK, Gibbert
K, Roggendorf M, Liu J, Lu M, Kraft AR, Teichgräber V, Hasenkrug KJ
and Dittmer U: Virus-specific CD8+ T cells upregulate
programmed death-1 expression during acute friend retrovirus
infection but are highly cytotoxic and control virus replication. J
Immunol. 187:3730–3737. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tassiopoulos K, Landay A, Collier AC,
Connick E, Deeks SG, Hunt P, Lewis DE, Wilson C and Bosch R:
CD28-negative CD4+ and CD8+ T cells in
antiretroviral therapy-naive HIV-infected adults enrolled in adult
clinical trials group studies. J Infect Dis. 205:1730–1738. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schurich A, Khanna P, Lopes AR, Han KJ,
Peppa D, Micco L, Nebbia G, Kennedy PT, Geretti AM, Dusheiko G and
Maini MK: Role of the coinhibitory receptor cytotoxic T lymphocyte
antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B
virus infection. Hepatology. 53:1494–1503. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lopes AR, Kellam P, Das A, Dunn C, Kwan A,
Turner J, Peppa D, Gilson RJ, Gehring A, Bertoletti A and Maini MK:
Bim-mediated deletion of antigen-specific CD8 T cells in patients
unable to control HBV infection. J Clin Invest. 118:1835–1845.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fisicaro P, Valdatta C, Massari M, Loggi
E, Biasini E, Sacchelli L, Cavallo MC, Silini EM, Andreone P,
Missale G and Ferrari C: Antiviral intrahepatic T-cell responses
can be restored by blocking programmed death-1 pathway in chronic
hepatitis B. Gastroenterology. 138:682–693. 693.e1–e4. 2010.
View Article : Google Scholar
|
|
13
|
Schurich A, Pallett LJ, Lubowiecki M,
Singh HD, Gill US, Kennedy PT, Nastouli E, Tanwar S, Rosenberg W
and Maini MK: The third signal cytokine IL-12 rescues the
anti-viral function of exhausted HBV-specific CD8 T cells. PLoS
Pathog. 9:e10032082013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bengsch B, Martin B and Thimme R:
Restoration of HBV-specific CD8+ T-cell function by PD-1
blockade in inactive carrier patients is linked to T-cell
differentiation. J Hepatol. 61:1212–1219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chinese Society of Hepatology and Chinese
Society of Infectious Diseases Chinese Medical Association: The
guideline of prevention and treatment for chronic hepatitis B (2010
version). Zhonghua Gan Zang Bing Za Zhi. 19:13–24. 2011.In
Chinese.
|
|
16
|
Bunce M: PCR-sequence-specific primer
typing of HLA class I and class II alleles. Methods Mol Biol.
210:143–171. 2003.
|
|
17
|
Mikami N and Sakaguchi S: CD28 signals the
differential control of regulatory T cells and effector T cells.
Eur J Immunol. 44:955–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deng M, Li MH, Liu SA, Liu F, Sang Y, Song
SJ, Zang SF, Guan XP, Yao X, Wu XP, et al: Studies about the level
of CD4+ CD25+ regulatory T cells and relation
between expression of Foxp3 and CD127 in peripheral blood of
chronic HBV infection. Zhonghua Shi Yan He Lin Chuang Bing Du Xue
Za Zhi. 24:21–23. 2010.In Chinese. PubMed/NCBI
|
|
19
|
Sojka DK, Hughson A and Fowell DJ: CTLA-4
is required by CD4+CD25+ Treg to control
CD4+ T-cell lymphopenia-induced proliferation. Eur J
Immunol. 39:1544–1551. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li M, Sun XH, Zhu XJ, Jin SG, Zeng ZJ,
Zhou ZH, Yu Z and Gao YQ: HBcAg induces PD-1 upregulation on
CD4+T cells through activation of JNK, ERK and PI3K/AKT
pathways in chronic hepatitis-B-infected patients. Lab Invest.
92:295–304. 2012. View Article : Google Scholar
|
|
21
|
Liu XY, Shi F, Zhao H and Wang HF:
Research of PD-1 expression in CD8+ T cell of peripheral
blood with HBV-associated acute-on-chronic liver failure. Zhonghua
Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 24:125–127. 2010.In
Chinese. PubMed/NCBI
|
|
22
|
Prendergast A, Klenerman P and Goulder P:
Expression of inducible costimulator (ICOS) on T cells is
associated with HIV disease progression. Aids Research and Human
Retroviruses. 24:1302008.
|
|
23
|
Jurado JO, Pasquinelli V, Alvarez IB,
Martínez GJ, Laufer N, Sued O, Cahn P, Musella RM, Abbate E,
Salomón H and Quiroga M: ICOS, SLAM and PD-1 expression and
regulation on T lymphocytes reflect the immune dysregulation in
patients with HIV-related illness with pulmonary tuberculosis. J
Int AIDS Soc. 15:174282012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rudd CE, Taylor A and Schneider H: CD28
and CTLA 4 coreceptor expression and signal transduction. Immuno
Rev. 229:12–26. 2009. View Article : Google Scholar
|
|
25
|
van Berkel ME and Oosterwegel MA: CD28 and
ICOS: Similar or separate costimulators of T cells? Immunol Lett.
105:115–122. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Simpson TR, Quezada SA and Allison JP:
Regulation of CD4 T cell activation and effector function by
inducible costimulator (ICOS). Curr Opin Immunol. 22:326–332. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nan XP, Zhang Y, Yu HT, Li Y, Sun RL, Wang
JP and Bai XF: Circulating CD4+CD25 high
regulatory T cells and expression of PD-1 and BTLA on
CD4+ T cells in patients with chronic hepatitis B virus
infection. Viral Immunol. 23:63–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Watanabe N, Gavrieli M, Sedy JR, Yang J,
Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, et
al: BTLA is a lymphocyte inhibitory receptor with similarities to
CTLA-4 and PD-1. Nat Immunol. 4:670–679. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Otsuki N, Kamimura Y, Hashiguchi M and
Azuma M: Expression and function of the B and T lymphocyte
attenuator (BTLA/CD272) on human T cells. Biochem Biophys Res
Commun. 344:1121–1127. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maini MK and Schurich A: The molecular
basis of the failed immune response in chronic HBV: Therapeutic
implications. J Hepatol. 52:616–619. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brooks DG, Teyton L, Oldstone MB and
McGavern DB: Intrinsic functional dysregulation of CD4 T cells
occurs rapidly following persistent viral infection. J Virol.
79:10514–10527. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Trautmann T, Kozik JH, Carambia A, Richter
K, Lischke T, Schwinge D, Mittrücker HW, Lohse AW, Oxenius A,
Wiegard C and Herkel J: CD4+ T-cell help is required for
effective CD8+ T cell-mediated resolution of acute viral
hepatitis in mice. PLoS One. 9:e863482014. View Article : Google Scholar
|
|
33
|
Chakir H, Wang H, Lefebvre DE, Webb J and
Scott FW: T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine
profile in mixed cell populations: Predominant role of GATA-3. J
Immunol Methods. 278:157–169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Szabo SJ, Sullivan BM, Stemmann C,
Satoskar AR, Sleckman BP and Glimcher LH: Distinct effects of T-bet
in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T
cells. Science. 295:338–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nasta F, Ubaldi V, Pace L, Doria G and
Pioli C: Cytotoxic T-lymphocyte antigen-4 inhibits GATA-3 but not
T-bet mRNA expression during T helper cell differentiation.
Immunology. 117:358–367. 2006. View Article : Google Scholar : PubMed/NCBI
|
